Company / FCF Margin
Processa Pharmaceuticals, Inc. FCF Margin History
FY2013-FY2016 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-769.9%
FY2016
5-year range
-2520.2% / -769.9%
FY2013-FY2016
Trend
+69.4%
vs FY2015
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -821.3% to -769.9% over the past 2 years.
Based on SEC 10-K filings.
-769.9% in FY2016 with a 3-year CAGR of +389.0%.
Improved from -821.3% to -769.9% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +389.0pp
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2016, fcf margin increased 69.4% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | - | - |
| FY2021 | - | - |
| FY2016 | -769.9% | +69.4% |
| FY2015 | -2520.2% | -206.9% |
| FY2014 | -821.3% | +29.1% |
| FY2013 | -1158.9% | - |
As of FY2016 · SEC 10-K · Updated Jun 28, 2026